SAITTA, Carlo
 Distribuzione geografica
Continente #
EU - Europa 2.233
NA - Nord America 2.171
AS - Asia 505
SA - Sud America 10
OC - Oceania 7
AF - Africa 4
Totale 4.930
Nazione #
US - Stati Uniti d'America 2.164
IE - Irlanda 688
SE - Svezia 548
IT - Italia 349
CN - Cina 343
PL - Polonia 200
DE - Germania 124
SG - Singapore 90
UA - Ucraina 88
FI - Finlandia 84
GB - Regno Unito 55
IN - India 51
BE - Belgio 35
FR - Francia 22
VN - Vietnam 18
CZ - Repubblica Ceca 13
BR - Brasile 10
CA - Canada 6
NL - Olanda 6
NZ - Nuova Zelanda 6
RU - Federazione Russa 6
AT - Austria 5
CH - Svizzera 4
GH - Ghana 4
ES - Italia 2
AU - Australia 1
BD - Bangladesh 1
EE - Estonia 1
GL - Groenlandia 1
HR - Croazia 1
HU - Ungheria 1
IQ - Iraq 1
IR - Iran 1
NO - Norvegia 1
Totale 4.930
Città #
Dublin 688
Chandler 513
Nyköping 333
Jacksonville 227
Warsaw 200
Messina 155
Ann Arbor 120
Beijing 119
Ashburn 112
Dearborn 107
Princeton 84
Medford 79
Cambridge 62
Des Moines 60
Singapore 57
Boardman 56
Houston 44
Bremen 39
New York 37
Brussels 35
Jinan 34
Helsinki 28
Los Angeles 26
Shenyang 26
Hyderabad 25
Pune 25
Wilmington 22
Nanjing 20
San Mateo 19
Dong Ket 18
Woodbridge 18
Lancaster 17
Catania 15
Haikou 15
Avola 13
Guangzhou 13
Tianjin 13
Hebei 12
Zhengzhou 11
Brasília 10
Hangzhou 10
Munich 10
Ningbo 10
Rome 10
Brno 9
Falls Church 9
Fuzhou 8
Palermo 8
Rosolini 8
Seattle 8
Taizhou 8
Nuremberg 7
Jiaxing 6
Norwalk 6
Whakatane 6
Santa Clara 5
Washington 5
Accra 4
Amsterdam 4
Hefei 4
Olomouc 4
Ottawa 4
Taiyuan 4
Vienna 4
Agira 3
Albino 3
Changsha 3
Chengdu 3
Kunming 3
Lanzhou 3
Lappeenranta 3
Nanchang 3
Piazza Armerina 3
San Filippo 3
Strasbourg 3
Augusta 2
Belpasso 2
Clearwater 2
Kemerovo 2
Leawood 2
Monmouth Junction 2
Naples 2
Pachino 2
Qingdao 2
Romainville 2
San Giuliano Milanese 2
Sassuolo 2
Scandicci 2
Siracusa 2
Tappahannock 2
Yicheng 2
Alcamo 1
Ardabil 1
Auburn Hills 1
Augsburg 1
Baghdad 1
Baotou 1
Barcelona 1
Berlin 1
Bologna 1
Totale 3.742
Nome #
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 129
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 126
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 107
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 99
Atrial fibrillation in patients with cirrhosis 98
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 95
Does the margin width influence recurrence rate in liver surgery for hepatocellular carcinoma smaller than 5 cm? 95
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 95
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? 91
Vitamin D Status in Rheumatoid Arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number 90
Pulse wave velocity and augmentation index, but notintima-media thickness, are early indicators ofvascular damage in hypercholesterolemic children 87
Biglycan expression, earlier vascular damage and pro-atherogenic profile improvement after smoke cessation in young people. 86
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 86
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 80
Potenziali indicatori di longevità in una popolazione di anziani siciliani 77
Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients 76
Ateromasia carotidea e livelli lipidici in soggetti affetti da DM2: risultati di una analisi retrospettiva 76
Obesity and liver cancer 74
Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis. 71
ANTIOXIDANT CAPACITY OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS (EPCS) AND CIGARETTE SMOKING 70
Extracellular superoxide dismutase (EC-SOD) gene mutations screening in a sample of Mediterranean population 68
A 1-year study on hydroxy-methylglutaryl coenzymea reductase gene expression and polymorphisms in hypercholesterolemic treated with statins. 67
Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians 66
null 66
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 66
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 66
Capacità antiossidante delle cellule progenitrici endoteliali ed abitudine al fumo di sigaretta 62
Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenarians. 60
Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress. 60
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 60
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 60
Tissue factor expression and activity are not increased in peripheral monocytes isolated from uncomplicated hypertensive patients 59
Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness 59
Biglycan expression is increased in hypertensive subjects with normal or increased carotid intima-media wall thickness 59
C-Reactive Protein (CRP) plasma levels, monocyte MCP-1 (Monocyte Chemoattractant Protein-1) and TF (Tissue Factor) mRNA in patients with primary arterial hypertension 59
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 59
Identification of extracellular superoxide dismutase, EC-SOD, mutations in a Sicilian population 56
Circulating progenitor cells and the elderly: a seven-year observational study. 56
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 55
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 54
Anatomic variations: a rare variant of formation of the portal vein 54
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 54
Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment 53
879 CHOLANGIOPATHY AND HCC IN MDR3 DEFICIENCY 53
Circulating progenitor cells and high density lipoprotein levels in elderly 52
The calm before the storm: A report from the International Liver Cancer Association Congress 2015 - Part 1 51
XXI National Congress of the Italian Society for the Study of Arteriosclerosis (SISA) 21–24 November, Perugia, Italy 50
null 50
Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness 49
The paraoxonase promoter polymorphism (-107)T > C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients 49
The changing scenario of hepatocellular carcinoma in Italy: an update 49
CIRCULATING PROGENITOR CELLS AND HIGH DENSITY LIPOPROTEIN LEVELS IN ELDERLY 48
Olmesartan and atorvastatin are effective in improving circulating progenitor cells profile in hypertensive subjects 48
Oxidative stress and flogosis: The role of endothelial progenitor cells in rheumathoid arthtritis 48
Platelet-activating factor acetylhydrolase is not associated with carotid intima-media thickness in hypercholesterolemic Sicilian individuals 47
Tissue Factor and Monocyte Chemoattractant Protein-1 expression in hypertensive subjects with normal or increased carotid intima-media thickness 46
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus hepatitis C virus-coinfected patients 45
PAF-AH gene polymorphisms and carotid atherosclerosis in sicilian hypercholesterolemic subjects 45
Left Ventricular Function in Hypertension: New Insight by Speckle Tracking Echocardiography. 45
Tissue factor and monocyte chemoattractant protein-1 expression in hypertensive individuals with normal or increased carotid intima-media wall thickness. 45
Virological profiles in hepatitis B virus / hepatitis C virus co-infected patients under interferon plus ribavirin therapy. 43
Fever and rhomboid target lesion in decompensated cirrhosis 43
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 43
The calm before the storm: A report from the International Liver Cancer Association Congress 2015 - Part 2 42
Erectile dysfunction in compensated liver cirrhosis 42
Occult hepatitis B virus and hepatocellular carcinoma. 41
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 41
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 41
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 40
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 38
null 38
Pattern of macrovascular invasion in hepatocellular carcinoma 36
null 36
Hepatocellular carcinoma: the point of view of the hepatitis B virus. 36
Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 35
Treatment of the Hepatitis B Virus and Hepatitis C Virus Combined Infection: Still a Challenge for the Hepatologist. 34
Toll-like receptor 3 and interleukine 1b expression in circulating progenitor cells isolated from patients with rheumatoid arthritis 34
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 34
Smoke exposure and circulating progenitor cells: Evidence for modulation of antioxidant enzymes and cell count 32
Integration of hepatitis B virus DNA in chronically infected patients assessed by Alu-PCR. 31
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 30
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia 29
Maternal and Neonatal Outcomes in Intrahepatic Cholestasis of Pregnancy 27
Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness. 27
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 26
Effects of the angiotensin II receptor blocker losartan on the monocyte expression of biglycan in hypertensive patients. 24
OCCULT HBV IS HIGHLY PREVALENT IN PATIENTS WITH INTRAHEPATIC CHOLANGIOCARCINOMA AND IT IS DETECTED AS BOTH FREE EPISOMAL AND INTEGRATED DNA 23
null 22
Vit d deficiency, depletion of circulating endothelial progenitor cells and impaired arterial stiffness in patients with ra 22
Mitochondrial DNA is a target of HBV integration 19
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 16
null 16
Proposal of model for personalized early adapted cancer screening in people living with HIV: experience of "Gaetano Martino" Hospital University of Messina 15
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 13
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 9
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 9
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 5
Arterial hypertension as a comorbidity of cirrhosis 5
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 4
Occult Hepatitis B Virus Infection: An Update 3
Totale 5.110
Categoria #
all - tutte 21.064
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.064


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020584 0 0 0 20 13 106 69 71 42 125 98 40
2020/2021729 55 23 161 44 113 49 46 50 26 96 30 36
2021/2022622 11 55 21 25 27 15 37 23 9 128 88 183
2022/20231.950 143 209 78 157 163 179 25 128 808 10 37 13
2023/2024498 37 81 28 42 33 111 3 27 2 49 22 63
2024/2025195 34 73 76 12 0 0 0 0 0 0 0 0
Totale 5.123